CHAMP1

Chromosome alignment-maintaining phosphoprotein 1 · Q96JM3 · CHAMP1 on Sugi Atlas →

0 patent compounds predicted against CHAMP1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CHAMP1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer PHASE3COMPLETED
Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment PHASE2COMPLETED
A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia PHASE2COMPLETED
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors PHASE1COMPLETED
AZD1775 for Advanced Solid Tumors PHASE1COMPLETED
Finding New Targets by Proteomic Approaches (InnovRT1) nanCOMPLETED
A Retrospective Study to Identify New Omics Biomarkers of Chronic/Persistent Low Back Pain nanCOMPLETED
Study on Aging and Cognitive Impairment in China nanRECRUITING
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung Cancer nanCOMPLETED
Analysis of Salivary Proteins in Young Children as an Device to Improve Caries Risk Assessment nanRECRUITING
S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid Leukemia nanCOMPLETED
Image-Guided Biopsies in Identifying Mechanisms of Resistance in Participants With Metastatic Castration Resistant Prostate Cancer Undergoing Radioligand Therapy nanWITHDRAWN
Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins nanCOMPLETED
Genetic and Epigenetic Variations in Heterokaryotypic Monozygotic Twins Discordant for Down Syndrome nanRECRUITING
Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane nanUNKNOWN
Precision High-Intensity Training Through Epigenetics (PHITE) nanCOMPLETED
Phosphoproteomic Profile of Children With Down Syndrome nanCOMPLETED
Towards an Easy-to-use Adrenal Cancer/Tumor Identity Card nanCOMPLETED
PCM1-JAK2 in Therapy Related Neoplasms nanUNKNOWN
The Role of TBC1D4 in Exercise- and Insulin-induced Glucose Metabolism in Human Skeletal Muscle nanCOMPLETED
Assessment Of Long Noncoding RNA CCAT1 In Colorectal Cancer Patients nanUNKNOWN
MOLECULAR REGULATION OF MUSCLE GLUCOSE METABOLISM (AIMS 2A, 2B, 3) nanUNKNOWN
Study of Biomarkers in Tissue Samples From Patients With Breast Cancer nanUNKNOWN
Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia nanCOMPLETED
HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors) nanUNKNOWN
Multi-level Molecular Profiling of High Acute Stress: a Clinical Study nanUNKNOWN
The Impact of Myomectomy on IVF Outcomes nanNOT_YET_RECRUITING
Ischemic Preconditioning - Perspectives of Use Vivio/in Vitro Studies nanENROLLING_BY_INVITATION

Related proteins — ESM-2 sequence neighbours (a CHAMP1 binder may also engage these)

ProteinNameSimilarity
Q8K327 0.999 Q8K327 →
Q9PU53 0.976 Q9PU53 →
F1LWT0 0.974 F1LWT0 →
Q8BHZ4 0.973 Q8BHZ4 →
Q96JE9 0.973 Q96JE9 →
Q9ULV3 0.972 Q9ULV3 →
Q63560 0.972 Q63560 →
Q9ULJ3 0.971 Q9ULJ3 →
Q96QH2 0.971 Q96QH2 →
Q7TSJ2 0.971 Q7TSJ2 →
E9Q6E9 0.970 E9Q6E9 →
Q92610 0.970 Q92610 →
BAZ2A Bromodomain adjacent to zinc finger domain protein 2A 0.969 landscape →
Q86YH2 0.969 Q86YH2 →
O14686 0.968 O14686 →
Q5F3G6 0.968 Q5F3G6 →
Q3V3Q4 0.968 Q3V3Q4 →
Q6BCL1 0.968 Q6BCL1 →
Q9JL04 0.968 Q9JL04 →
Q05A80 0.968 Q05A80 →
Q8WY36 0.967 Q8WY36 →
Q8BZ32 0.967 Q8BZ32 →
Q6PDK2 0.967 Q6PDK2 →
Q8N1P7 0.967 Q8N1P7 →
P86174 0.966 P86174 →
Q9BTC0 0.966 Q9BTC0 →
Q0VEE6 0.966 Q0VEE6 →
Q8CCJ9 0.966 Q8CCJ9 →
Q9JKB5 0.966 Q9JKB5 →
O43313 0.966 O43313 →